Saturday 17 October 2026
Export IOSP’s income statement to Excel — free account
Innospec Inc.
IOSP Basic Materials Specialty Chemicals
Innospec Inc.’s revenue for fiscal 2025 (year ended December 2025) was $1.8 billion, down 3.65% from fiscal 2024. In the quarter to June 2026, revenue grew 11.8%, EPS grew 33.0% and free cash flow fell 63.2%, each against the same quarter a year earlier. Dividend growth for ten consecutive years; insiders bought in the last twelve months.
96.81
0.21
+0.22%
Follow IOSP
Target Price Range
Analyst price targets
Free accountTen years at a glance Fiscal years to December
| Group | Line | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | Trend | 2026e | 2027e | 2028e |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Price, $ | |||||||||||||||
| Price, $ | Low | 41.61 | 54.10 | 53.07 | 56.94 | 56.71 | 81.00 | 83.13 | 91.74 | 103.97 | 70.10 |
Analyst estimates 2026–2028 Powerpack |
|||
| High | 73.40 | 74.75 | 83.20 | 107.10 | 107.85 | 107.73 | 115.66 | 125.87 | 133.71 | 117.08 | |||||
| People | |||||||||||||||
| People | Employees | 1,800 | 1,900 | 2,000 | 2,000 | 1,900 | 1,900 | 2,100 | 2,400 | 2,450 | 2,450 | ||||
| Revenue/emp, $m | 0.49 | 0.69 | 0.74 | 0.76 | 0.63 | 0.78 | 0.94 | 0.81 | 0.75 | 0.73 | |||||
| Income, $m | |||||||||||||||
| Income, $m | Revenue | 883 | 1,307 | 1,477 | 1,513 | 1,193 | 1,483 | 1,964 | 1,949 | 1,845 | 1,778 | ||||
| Gross margin, % | 37.62 | 30.86 | 29.45 | 30.81 | 28.72 | 29.32 | 29.88 | 30.33 | 29.42 | 27.69 | |||||
| EBT | 103 | 128 | 132 | 150 | 40 | 134 | 185 | 174 | 41 | 138 | |||||
| EBT margin, % | 11.67 | 9.80 | 8.91 | 9.94 | 3.33 | 9.06 | 9.40 | 8.95 | 2.23 | 7.77 | |||||
| Net income | 81 | 62 | 85 | 112 | 29 | 93 | 133 | 139 | 36 | 117 | |||||
| Depreciation | 38 | 50 | 50 | 48 | 66 | 43 | 40 | 39 | 44 | 44 | |||||
| Per share, $ | |||||||||||||||
| Per share, $ | Revenue | 36.81 | 54.12 | 60.53 | 61.81 | 48.57 | 60.19 | 79.22 | 78.42 | 74.02 | 71.46 | ||||
| Earnings | 3.39 | 2.56 | 3.48 | 4.58 | 1.17 | 3.78 | 5.37 | 5.60 | 1.43 | 4.69 | |||||
| Cash flow | 4.40 | 3.42 | 4.30 | 6.60 | 5.94 | 3.78 | 3.30 | 8.34 | 7.40 | 5.56 | |||||
| Capex | (0.69) | (1.33) | (1.23) | (1.27) | (1.21) | (1.47) | (1.70) | (3.10) | (2.48) | (2.99) | |||||
| Free cash flow | 3.71 | 2.09 | 3.07 | 5.33 | 4.73 | 2.31 | 1.60 | 5.24 | 4.92 | 2.57 | |||||
| Book value | 27.24 | 32.89 | 33.83 | 37.53 | 38.47 | 41.91 | 41.97 | 46.26 | 48.78 | 53.57 | |||||
| Shares, m | 24 | 24 | 24 | 24 | 25 | 25 | 25 | 25 | 25 | 25 | |||||
| Valuation, × | |||||||||||||||
| Valuation, × | P/E | 20.44 | 27.81 | 17.75 | 22.59 | 77.55 | 23.90 | 19.32 | 21.82 | 76.97 | 16.35 | ||||
| P/S | 1.89 | 1.32 | 1.02 | 1.67 | 1.87 | 1.50 | 1.31 | 1.56 | 1.49 | 1.07 | |||||
| P/B | 2.55 | 2.16 | 1.83 | 2.76 | 2.36 | 2.16 | 2.47 | 2.64 | 2.26 | 1.43 | |||||
| EV/Sales | 2.08 | 1.42 | 1.08 | 1.68 | 1.80 | 1.42 | 1.24 | 1.46 | 1.34 | 0.92 | |||||
| EV/FCF | 22.11 | 36.65 | 21.30 | 19.43 | 18.64 | 37.68 | 61.64 | 21.92 | 20.18 | 25.56 | |||||
| Cash, $m | |||||||||||||||
| Cash, $m | Operating cash flow | 106 | 83 | 105 | 162 | 146 | 93 | 82 | 207 | 185 | 138 | ||||
| Capex | (16) | (32) | (30) | (31) | (30) | (36) | (42) | (77) | (62) | (74) | |||||
| Free cash flow | 89 | 51 | 75 | 131 | 116 | 57 | 40 | 130 | 123 | 64 | |||||
| Balance, $m | |||||||||||||||
| Balance, $m | Working capital | 258 | 300 | 367 | 327 | 314 | 392 | 467 | 514 | 585 | 645 | ||||
| Total debt | 272 | 222 | 209 | 59 | 0 | 36 | 45 | — | — | — | |||||
| Net debt | 170 | 131 | 86 | (17) | (105) | (142) | (147) | (204) | (289) | (292) | |||||
| Shareholders’ equity | 654 | 794 | 826 | 919 | 945 | 1,033 | 1,040 | 1,150 | 1,216 | 1,333 | |||||
| Returns, % | |||||||||||||||
| Returns, % | ROA | 7.36 | 4.77 | 5.90 | 7.63 | 2.00 | 6.27 | 8.38 | 8.40 | 2.07 | 6.54 | ||||
| ROIC | 7.45 | 8.44 | 9.15 | 10.38 | 2.51 | 9.26 | 13.10 | 10.68 | 12.00 | 7.78 | |||||
| ROE | 12.91 | 8.54 | 10.50 | 12.86 | 3.08 | 9.41 | 12.83 | 12.70 | 3.01 | 9.15 | |||||
Negative figures in brackets.
Fiscal years to Dec 2025 · latest quarter Jun 2026
Charts ten years each
Innospec Inc. vs peers in Specialty Chemicals (Q) = latest quarter vs a year earlier
| Company | Market cap | P/E | Fwd P/E | Revenue growth (Q) | EPS growth (Q) | FCF growth (Q) | Gross margin (Q) | EBIT margin (Q) | Compare |
|---|---|---|---|---|---|---|---|---|---|
| ASH Ashland Inc. | $3.3B | 62.4× | 24.9× | +7.34% (above 0%: growing) | n/m | +5.26% (above 0%: growing) | 34.21% | 8.65% | Compare |
| FUL H. B. Fuller Company | $2.8B | 14.1× | 16.8× | +5.17% (above 0%: growing) | +18.19% (above 0%: growing) | −58.41% (below 0%: shrinking) | 33.22% | 12.07% | Compare |
| HWKN Hawkins, Inc. | $2.8B | 33.8× | 36.3× | +7.64% (above 0%: growing) | −3.55% (below 0%: shrinking) | +30.29% (above 0%: growing) | 23.44% | 12.25% | Compare |
| KWR Quaker Houghton | $2.7B | 27.9× | 25.2× | +10.17% (above 0%: growing) | n/m | −43.19% (below 0%: shrinking) | 35.53% | 7.62% | Compare |
| WDFC WD-40 Company | $2.7B | 30.3× | 34.0× | +24.35% (above 0%: growing) | +45.45% (above 0%: growing) | −13.28% (below 0%: shrinking) | 56.59% | 20.67% | Compare |
| NGVT Ingevity Corporation | $2.4B | 45.3× | 18.5× | −5.25% (below 0%: shrinking) | n/m | −136.08% (below 0%: shrinking) | 44.25% | 19.13% | Compare |
| IOSP Innospec Inc. | $2.4B | 19.7× | 16.3× | +11.76% (above 0%: growing) | +32.98% (above 0%: growing) | −63.16% (below 0%: shrinking) | 28.14% | 8.08% | |
| MTX Minerals Technologies Inc. | $2.0B | — (loss-making) | 12.4× | +3.69% (above 0%: growing) | n/m | +5.92% (above 0%: growing) | 24.40% | (40.17%) | Compare |
| CC The Chemours Company | $1.9B | — (loss-making) | 16.9× | −1.49% (below 0%: shrinking) | n/m | +128.00% (above 0%: growing) | 17.98% | (13.39%) | Compare |
| Median of peers | $2.7B | 32.1× | 21.7× | +6.26% | +18.19% | −4.01% | 33.72% | 10.36% |
Innospec Inc. (IOSP) key facts
- Concern: Innospec Inc.’s revenue for fiscal 2025 (year ended December 2025) was $1.8 billion, down 3.65% from fiscal 2024.
- Innospec Inc. (IOSP) is a Specialty Chemicals company in the Basic Materials sector, listed on Nasdaq.
- As of October 16, 2026, IOSP traded at $96.81, a market capitalization of $2.4 billion.
- Innospec Inc. pays an annual dividend of $1.79 per share, a yield of 1.85%, with a payout ratio of 36.5%.
- Return on equity was 9.15% and debt-to-equity 0.00.
- Its Piotroski F-score is 7 out of 9 and its Altman Z-score is 4.75 (safe zone) for fiscal 2025.